Cognition Therapeutics (CGTX) Balance Sheet: Assets & Liabilities

Cognition Therapeutics (CGTX) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Cognition Therapeutics reported total assets of $48.39M and total liabilities of $14.12M. Shareholders' equity was $34.27M, up 82.8% from $18.75M a year earlier. Total debt stood at $638.00K against $36.81M in cash and short-term investments, a net cash position of $36.17M. That puts debt-to-equity at 0.02, compared with 0.03 a year earlier.

Cognition Therapeutics Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Cognition Therapeutics, Inc. (CGTX) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Current Assets
Cash and Cash Equivalents	36.81	25.01	29.92	41.56	54.72	5.19	2.89
Cash & Short-Term Investments	36.81	25.01	29.92	41.56	54.72	5.19	2.89
Accounts Receivable	9.92	2.69	1.28	3.67	2.27	1.15	4.12
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.12
Other Current Assets	1.26	1.86	3.02	2.41	2.01	0.57	0.03
Total Current Assets	47.99	29.56	34.22	47.65	58.99	6.91	7.16
Non-Current Assets
Property, Plant & Equipment (Net)	0.40	0.68	0.94	1.05	0.15	0.21	0.30
Other Non-Current Assets	0.00	0.00	0.00	1.73	0.00	0.00	0.00
Total Non-Current Assets	0.40	0.68	0.94	2.78	0.15	0.21	0.30
Total Assets	48.39	30.23	35.16	50.43	59.14	7.12	7.46
Current Liabilities
Accounts Payable	1.12	1.98	3.70	3.22	4.17	2.00	2.36
Short-Term Debt	0.44	0.28	0.72	0.78	0.00	0.00	0.00
Accrued Liabilities	12.00	7.62	4.06	2.09	0.47	0.99	-
Deferred Revenue	0.37	1.07	1.70	1.70	0.75	0.00	1.32
Other Current Liabilities	12.00	0.28	4.06	0.63	1.19	1.25	0.00
Total Current Liabilities	13.92	11.14	10.17	7.80	7.86	3.25	3.68
Non-Current Liabilities
Long-Term Debt	0.20	0.34	0.52	0.70	0.00	12.85	6.90
Deferred Tax Liabilities	0.00	0.00	0.00	-0.70	0.00	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	1.69	0.00	59.20	55.30
Total Non-Current Liabilities	0.20	0.34	0.52	2.38	0.00	72.05	62.20
Total Liabilities	14.12	11.48	10.69	10.18	7.86	75.30	65.88
Stockholders' Equity
Common Stock	0.09	0.06	0.03	0.03	0.02	0.00	0.00
Retained Earnings	-198.65	-175.16	-141.19	-115.40	-94.00	-68.22	-58.24
Accumulated Other Comprehensive Income	0.00	0.00	-0.20	-0.20	-0.20	-0.19	-0.19
Additional Paid-in Capital	232.83	193.85	165.83	155.82	145.45	0.22	0.00
Shares Outstanding	88.90	59.85	32.17	28.99	22.23	-	-
Total Stockholders' Equity	34.27	18.75	24.47	40.25	51.27	-68.18	-58.42
Total Liabilities & Equity	48.39	30.23	35.16	50.43	59.14	7.12	7.46

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Cognition Therapeutics Balance Sheet

How much debt does Cognition Therapeutics have?

Cognition Therapeutics had total debt of $638.00K as of Dec 31, 2025, against $36.81M in cash and short-term investments. Its debt-to-equity ratio was 0.02. Total debt was $621.00K a year earlier.

What are Cognition Therapeutics's total assets?

Cognition Therapeutics reported total assets of $48.39M as of Dec 31, 2025, up 60.1% from $30.23M a year earlier. Total liabilities were $14.12M.

What is Cognition Therapeutics's shareholders' equity?

Cognition Therapeutics's shareholders' equity was $34.27M as of Dec 31, 2025, or about $0.39 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition